Biometric data from higi will be integrated with clinical, claims, and genomic data from Interpreta under a partnership designed to enable physicians and insurers to create personalized-care “roadmaps” for patients.
The partnership will rely on data collected by higi at its nearly 11,000 FDA-cleared, self-screening health stations—the largest such network in North America, the company says. The stations are designed to capture biometric data from shoppers at locations within food, chain drug, mass merchant, and club retailers.
According to higi, 78% of the U.S. population lives within 5 miles of one of its health stations, which have been used by more than 43 million consumers.
Data collected from those stations includes blood pressure, pulse, BMI, weight, body composition, and self-screening questions. Through the collaboration, that data can be accessed by users through higi’s mobile and web app, then interpreted and integrated with clinical, claims and genomic data in real time by Interpreta, a San Diego, CA-based healthcare analytics company.
“Interpreta and higi hope to transform the way healthcare is delivered,” Interpreta CEO and cofounder Ahmed Ghouri, M.D., said. “In addition to biometric data, there is a strong thesis that continuous engagement with patients, outside of the 15-minute annual office visit, will provide a way for patients to stay aware of their health and for providers to stay in touch with them.”
Ghouri and Khan Siddiqui, M.D., higi’s CTO and CMO, said their companies aim to close gaps in healthcare by promoting greater engagement and sharing of data by physicians and their patients.
Click here to access the rest of this article.